Increased risk of cancer and mortality in ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Increased risk of cancer and mortality in a large French population-based paediatric-onset inflammatory bowel disease retrospective cohort.
Auteur(s) :
Dupont-Lucas, Claire [Auteur]
Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau [ADEN]
Leroyer, Ariane [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Ley, Delphine [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Spyckerelle, Claire [Auteur]
Groupement des Hôpitaux de l'Institut Catholique de Lille [GHICL]
Bertrand, Valérie [Auteur]
Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) [GHH]
Turck, Dominique [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Savoye, Guillaume [Auteur]
Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau [ADEN]
Maunoury, Vincent [Auteur]
Hôpital Claude Huriez [Lille]
Guillon, Nathalie [Auteur]
Registre EPIMAD
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Fumery, Mathurin [Auteur]
Périnatalité et Risques Toxiques - UMR INERIS_I 1 UPJV [PERITOX]
Sarter, Helene [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Gower, Corinne [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau [ADEN]
Leroyer, Ariane [Auteur]

Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Ley, Delphine [Auteur]

Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Spyckerelle, Claire [Auteur]
Groupement des Hôpitaux de l'Institut Catholique de Lille [GHICL]
Bertrand, Valérie [Auteur]
Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) [GHH]
Turck, Dominique [Auteur]

Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Savoye, Guillaume [Auteur]
Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau [ADEN]
Maunoury, Vincent [Auteur]
Hôpital Claude Huriez [Lille]
Guillon, Nathalie [Auteur]

Registre EPIMAD
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Fumery, Mathurin [Auteur]

Périnatalité et Risques Toxiques - UMR INERIS_I 1 UPJV [PERITOX]
Sarter, Helene [Auteur]

Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Gower, Corinne [Auteur]

Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Titre de la revue :
Journal of Crohn's and Colitis
Nom court de la revue :
J Crohns Colitis
Numéro :
17
Pagination :
524–534
Date de publication :
2022-11-04
ISSN :
1876-4479
Mot(s)-clé(s) en anglais :
Crohn's disease
ulcerative colitis
cohort study
ulcerative colitis
cohort study
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background and Aims
Paediatric-onset IBD [pIBD] is associated with an increased risk of cancer and mortality in adulthood. The aims of this study were to measure the incidence of cancer and mortality in patients with ...
Lire la suite >Background and Aims Paediatric-onset IBD [pIBD] is associated with an increased risk of cancer and mortality in adulthood. The aims of this study were to measure the incidence of cancer and mortality in patients with pIBD and identify factors associated with mortality and cancer. Methods All patients diagnosed with Crohn’s disease [CD] or ulcerative colitis [UC] before the age of 17 years between 1988 and 2011 in the EPIMAD registry were retrospectively followed until 2013 for cancer and 2015 for mortality. Standardized incidence [SIR] and mortality ratios [SMR] were estimated compared to the general population. Cox regression was used to compare the effect of exposures on cancer and mortality among IBD patients. Results We included 1344 patients [52% males, 75% CD], totalling 12 957 patient-years for cancer incidence and 18 817 patient-years for mortality. There were 14 cases of cancer [median age 27.8 years] and 15 deaths [median age 28.8 years]. The incidence of cancer and of mortality were increased compared to the general population: all-cancer SIR = 2.7 (95% confidence interval [CI]: 1.5–4.8), SMR = 1.7 [95% CI: 1.0–2.8]. Colorectal cancer had the highest SIR and SMR: SIR = 41.2 [95% CI: 17.2–99.0], SMR = 70.4 [95% CI 22.7–218.2]. Cancer was associated with (hazard ratio [HR], 95% CI): active smoking at diagnosis [5.5, 1.8–16.5], p = 0.002; any exposure to anti-tumour necrosis factor [6.1, 1.7–22.3], p = 0.0065; and exposure to combination therapy [7.4, 1.8–29.7], p = 0.0047. Mortality was associated with extraintestinal manifestations (HR 4.9 [95% CI: 1.7–13.8], p = 0.003). Conclusions In this large population-based cohort, patients with pIBD had an increased risk of both cancer [2.7-fold] and mortality [1.7-fold], particularly for colorectal cancer.Lire moins >
Lire la suite >Background and Aims Paediatric-onset IBD [pIBD] is associated with an increased risk of cancer and mortality in adulthood. The aims of this study were to measure the incidence of cancer and mortality in patients with pIBD and identify factors associated with mortality and cancer. Methods All patients diagnosed with Crohn’s disease [CD] or ulcerative colitis [UC] before the age of 17 years between 1988 and 2011 in the EPIMAD registry were retrospectively followed until 2013 for cancer and 2015 for mortality. Standardized incidence [SIR] and mortality ratios [SMR] were estimated compared to the general population. Cox regression was used to compare the effect of exposures on cancer and mortality among IBD patients. Results We included 1344 patients [52% males, 75% CD], totalling 12 957 patient-years for cancer incidence and 18 817 patient-years for mortality. There were 14 cases of cancer [median age 27.8 years] and 15 deaths [median age 28.8 years]. The incidence of cancer and of mortality were increased compared to the general population: all-cancer SIR = 2.7 (95% confidence interval [CI]: 1.5–4.8), SMR = 1.7 [95% CI: 1.0–2.8]. Colorectal cancer had the highest SIR and SMR: SIR = 41.2 [95% CI: 17.2–99.0], SMR = 70.4 [95% CI 22.7–218.2]. Cancer was associated with (hazard ratio [HR], 95% CI): active smoking at diagnosis [5.5, 1.8–16.5], p = 0.002; any exposure to anti-tumour necrosis factor [6.1, 1.7–22.3], p = 0.0065; and exposure to combination therapy [7.4, 1.8–29.7], p = 0.0047. Mortality was associated with extraintestinal manifestations (HR 4.9 [95% CI: 1.7–13.8], p = 0.003). Conclusions In this large population-based cohort, patients with pIBD had an increased risk of both cancer [2.7-fold] and mortality [1.7-fold], particularly for colorectal cancer.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
Institut Pasteur de Lille
CHU Lille
Institut Pasteur de Lille
Date de dépôt :
2023-10-20T05:58:24Z
2024-03-13T12:28:34Z
2024-03-13T12:28:34Z